Coumarin derivatives useful as TNFα inhibitors
US7026491B2 · kind B2 · utility
3Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2001 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Aug 4, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds composition capable of inhibiting TNFα and having antiimmunoinflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these novel compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.